Mechanical failure of the latex condom in a cohort of women at high STD risk

被引:67
作者
Macaluso, M
Kelaghan, J
Artz, L
Austin, H
Fleenor, M
Hook, EW
Valappil, T
机构
[1] Univ Alabama, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA
[2] NICHHD, Rockville, MD USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Jefferson Cty Dept Hlth, Birmingham, AL USA
关键词
D O I
10.1097/00007435-199909000-00006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: Mechanical failure may reduce the efficacy of condoms. Little is known about frequency and determinants of condom failure in groups at high risk of sexually transmitted diseases (STD). Goal: To measure condom breakage and slippage rates and evaluate potential determinants of failure among women attending a public STD clinic. Study Design: Women attending an STD clinic participated in a 6-month prospective study of barrier contraception fur the prevention of STD, They completed sexual diaries that were reviewed at monthly follow-up visits, No data mere collected from the male partners. Baseline characteristics of the participants and time-dependent behaviors were evaluated as potential determinants of condom failure. Results: Of 21,852 condoms used by 892 women, 500 broke during intercourse (2.3%) and 290 slipped (1.3%). Breakage was more common among young, black, single nulliparae who engaged in high-risk behavior. Slippage was more common among married women with children, Failure rates decreased with condom use, with coital frequency, and with use of spermicides. Conclusion: User characteristics and experience are determinants of breakage and slippage, which are often regarded only as the effect of product design flaws. Attention to modifiable determinants of failure may improve user counseling and product labeling.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 33 条
[11]   INVITRO EVALUATIONS OF CONDOMS WITH AND WITHOUT NONOXYNOL-9 AS PHYSICAL AND CHEMICAL BARRIERS AGAINST CHLAMYDIA-TRACHOMATIS, HERPES-SIMPLEX VIRUS TYPE-2, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
JUDSON, FN ;
EHRET, JM ;
BODIN, GF ;
LEVIN, MJ ;
RIETMEIJER, CAM .
SEXUALLY TRANSMITTED DISEASES, 1989, 16 (02) :51-56
[12]  
JUDSON FN, 1989, AIDS UPDATES, V2, P1
[13]   EFFICACY OF THE CONDOM AS A BARRIER TO THE TRANSMISSION OF CYTOMEGALOVIRUS [J].
KATZNELSON, S ;
DREW, WL ;
MINTZ, L .
JOURNAL OF INFECTIOUS DISEASES, 1984, 150 (01) :155-157
[14]   AN ANCIENT METHOD AND A MODERN SCOURGE - THE CONDOM AS A BARRIER AGAINST HERPES [J].
KISH, LS ;
MCMAHON, JT ;
BERGFELD, WF ;
PELACHYK, JM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 9 (05) :769-770
[15]  
KOOP CE, 1988, HHS PUBLICATION CDC
[16]  
Littell R.C., 1996, SAS SYSTEM MIXED MOD, P423
[17]   Prospective study of barrier contraception for the prevention of sexually transmitted diseases study design and general characteristics of the study group [J].
Macaluso, M ;
Artz, L ;
Kelaghan, J ;
Austin, H ;
Fleenor, M ;
Hook, EW .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (03) :127-136
[18]   EFFICACY OF COMMERCIAL CONDOMS IN THE PREVENTION OF HEPATITIS-B VIRUS-INFECTION [J].
MINUK, GY ;
BOHME, CE ;
BOWEN, TJ ;
HOAR, DI ;
CASSOL, S ;
GILL, MJ ;
CLARKE, HD .
GASTROENTEROLOGY, 1987, 93 (04) :710-714
[19]  
PERLMAN JA, 1990, J ACQ IMMUN DEF SYND, V3, P155
[20]  
REITMEIJER CAM, 1988, JAMA-J AM MED ASSOC, V259, P1851